Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-γ2 gene polymorphisms

British Journal of Nutrition

Volumn 96, Issue 5, 2006, Pages 965-972

  Goyenechea, Estibaliz ^a   Parra, M Dolores ^a   Martínez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Gene nutrient interactions; Interleukin 6; Obesity; Weight loss

Indexed keywords

ALANINE; CYTOSINE; GUANINE; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC RESTRICTION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK ASSESSMENT; STATISTICAL ANALYSIS; TREATMENT DURATION; VOLUNTEER; WEIGHT CONTROL; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METHODOLOGY;

ADULT; ALLELES; BIOLOGICAL MARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; CALORIC RESTRICTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; OBESITY; POLYMORPHISM, GENETIC; PPAR GAMMA; WEIGHT GAIN; WEIGHT LOSS;

EID: 33846612310     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/BJN20061901     Document Type: Article

References (53)

1. Abeke I, Parra MD & Martinez JA (2006) Different dietary strategies for weight less in obesity: role of energy and macronutrient content. Nutr Res Rev 19, 1-14.
2. Aronne LJ (1998) Obesity. Med Clin North Am 82, 161-181.
3. Auwerx J (1999) PPARgamma, the ultimate thrifty gene. Diabetologia 42, 1033-1049.
4. Barbieri M, Rizzo MR, Papa M, Acampora R, De Angelis L, Olivieri F, Marchegiani F, Franceschi C & Paolisso G (2005) Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Exp Gerontol 40, 599-604.
5. Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin LJ, Andres R, Roth J & Shuldiner AR (1998) Association of the Pro12A1a variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes 47, 1806-1808.
6. Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud'homme D, Despres JP & Vohl MC (2003) The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 48, 14-19.
7. Dedoussis GV, Manios Y, Choumerianou DM, Yiannakouris N, Panagiotakos DB, Skenderi K & Zampelas A (2004) The IL-6 gene G-174C polymorphism related to health indices in Greek primary school children. Obes Res 12, 1037-1041.
8. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W & Auwerx J (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20, 284-287.
9. Ek J, Urhammer SA, Sorensen TI, Andersen T, Auwerx J & Pedersen O (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42, 892-895.
10. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919.
11. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C & Ricart W (2000a) Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49, 517-520.
12. Fernandez-Real JM, Broch M, Vendrell J, Richart C & Ricart W (2000b) Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85, 1334-1339.
13. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S & Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102, 1369-1376.
14. Goyenechea E, Parra MD & Martinez JA (2005) Role of IL-6 and its -174G > C polymorphism in weight management and in the metabolic comorbidities associated with obesity. An Sist Sanit Navar 28, 357-366.
15. Greenwald A (2006) Current nutritional treatments of obesity. Adv Psychosom Med 27, 24-41.
16. Halverstadt A, Phares DA, Roth S, Ferrell RE, Goldberg AP & Hagberg JM (2005) Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim Biophys Acta 1734, 143-151.
17. Hamid YH, Rose CS, Urhammer SA, et al. (2005) Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48, 251-260.
18. Hara K, Kubota N, Tobe K, et al. (2000) The role of PPARγ as a thrifty gene both in mice and humans. Br J Nutr 84, Suppl. 2, S235-S239.
19. Humphries SE, Luong LA, Ogg MS, Hawe E & Miller GJ (2001) The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22, 2243-2252.
20. Jiang C, Ting AT & Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
21. Kubaszek A, Pihlajamaki J, Punnonen K, Karhapaa P, Vauhkonen I & Laakso M (2003) The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52, 558-561.
22. Labayen I, Diez N, Parra D, Gonzalez A & Martinez JA (2004) Basal and postprandial substrate oxidation rates in obese women receiving two test meals with different protein content. Clin Nutr 23, 571-578.
23. Lachin JM (2005) A review of methods for futility stopping based on conditional power. Stat Med 24, 2747-2764.
24. Lieb W, Pavlik R, Erdmann J, et al. (2004) No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 97, 205-212.
25. Lindi V, Sivenius K, Niskanen L, Laakso M & Uusitupa MI (2001) Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 44, 925-926.
26. Lindi VI, Uusitupa MI, Lindstrom J, et al. (2002) Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51, 2581-2586.
27. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G & Colantuoni V (1999) Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes 48, 1466-1468.
28. Marti A, Corbalan MS, Martinez-Gonzalez MA, Forga L & Martinez JA (2002) CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene. J Physiol Biochem 58, 219-220.
29. Marti A, Moreno-Aliaga MJ, Hebebrand J & Martinez JA (2004) Genes, lifestyles and obesity. Int J Obes Relat Metab Disord 28, Suppl. 3, S29-S36.
30. Martinez JA (2000) Body-weight regulation: causes of obesity. Proc Nutr Soc 59, 337-345.
31. Martinez-Gonzalez MA, Martinez JA, Hu FB, Gibney MJ & Kearney (1999) Physical inactivity, sedentary lifestyle and obesity in the European Union. Int J Obes Relat Metab Disord 23, 1192-1201.
32. Masugi J, Tamori Y, Mori H, Koike T & Kasuga M (2000) Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun 268, 178-182.
33. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S & Coppack SW (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82, 4196-4200.
34. Moreno-Aliaga MJ, Campion J, Milagro FI, Berjón A & Martinez JA (2005) Adiposity and proinflammatory state: the chicken or the egg. Adipocytes 1, 1-16.
35. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE & Shuldiner AR (2001) Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 50, 2172-2176.
36. Ochoa MC, Marti A, Azcona C, et al. (2004) Gene-gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents. Int J Obes Relat Metab Disord 28, Suppl. 3, S37-S41.
37. Parra MD, Martinez de Morentin BE & Martinez JA (2005) Postprandial insulin response and mitochondrial oxidation in obese men nutritionally treated to lose weight. Eur J Clin Nutr 59, 334-340.
38. Pérez S, Parra MD, Martínez de Morentin B, Rodríguez MC & Martínez JA (2005) Evaluación de la variabilidad intraindividual de la medida de composición corporal mediante bioimpedancia en voluntarias sanas y su relación con el índice de masa corporal y el pliegue tricipital (Evaluation of intraindividual variability in the measurement of body composition using electrical bioimpedance in healthy volunteers and its relationship with body mass index and triceps skinfold measurement). Enferm Clin 15, 343-347.
39. Poitou C, Lacorte JM, Coupaye M, et al. (2005) Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg 15, 11-23.
40. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Perusse L & Bouchard C (2006) The human obesity gene map: the 2005 update. Obesity 14, 529-644.
41. Ricote M, Li AC, Willson TM, Kelly CJ & Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79-82.
42. Sesti G, Perego L, Cardellini M, et al. (2005) Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab 90, 5064-5069.
43. Trayhurn P & Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355.
44. Trayhurn P & Wood IS (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33, 1078-1081.
45. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I & Chrousos GP (1997) Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66, 54-62.
46. Vogels N, Diepvens K & Westerterp-Plantenga MS (2005a) Predictors of long-term weight maintenance. Obes Res 13, 2162-2168.
47. Vogels N, Mariman EC, Bouwman FG, Kester AD, Diepvens K & Westerterp-Plantenga MS (2005b) Relation of weight maintenance and dietary restraint to peroxisome proliferator-activated receptor gamma2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms. Am J Clin Nutr 82, 740-746.
48. Vozarova B, Fernandez-Real JM, Knowler WC, et al. (2003) The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 112, 409-413.
49. Weinsier RL, Hunter GR, Desmond RA, Byrne NM, Zuckerman PA & Darnell BE (2002) Free-living activity energy expenditure in women successful and unsuccessful at maintaining a normal body weight. Am J Clin Nutr 75, 499-504.
50. Wernstedt I, Eriksson AL, Berndtsson A, Hoffstedt J, Skrtic S, Hedner T, Hulten LM, Wiklund O, Ohlsson C & Jansson JO (2004) A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord 28, 1272-1279.
51. Wing RR & Phelan S (2005) Long-term weight loss maintenance. Am J Clin Nutr 82, Suppl. 1, S222-S225.
52. Wu Z, Xie Y, Bucher NL & Farmer SR (1995) Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 9, 2350-2363.
53. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J & Shuldiner AR (1997) Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241, 270-274.